EUnetHTA 21 announces public consultation for three deliverables

EUnetHTA 21 announces that the public consultation for D4.2 (scoping process), D4.3.2 (guideline for comparators and comparisons) and D4.7.1/4.7.2 (framework for assessment of high-risk MD) is open until 31-05-2022, 23:59 CET. The draft deliverable as well as the comment form can be found via this link. General principles for public consultation can be found here, please read […]

EMA and the EUnetHTA 21 consortium set priorities for their collaboration

The EUnetHTA 21 Consortium is pleased to announce that the EUnetHTA 21-EMA Work Plan is now publicly available. We would like to thank everyone who worked on this important document which will lay the groundwork for continued cooperation between EUnetHTA 21 and the European Medicines Agency. More information can be found here: EMA and the […]

EUnetHTA 21 launches 2nd Open Call for JSC in June 2022

EUnetHTA 21 launches the second Open Call for applications from the pharmaceutical industry for five Joint Scientific Consultations (JSC) in June 2022. The Open Call will remain open from 6 June, 2022 to 31 August, 2022. These five JSC will be consultations in parallel to EMA scientific advice and hence will focus on medicinal products, […]

D5.3 on selection criteria for assessor and co-assessor of Joint Clinical Assessments is open for public consultation between March 7 and April 5, 2022, 23:59 CET.

The public consultation for EUnetHTA 21 Deliverable 5.3 on selection criteria for assessor and co-assessor of Joint Clinical Assessments (JCA) is open for public consultation between March 7 and April 5, 2022, 23:59 CET. The draft deliverable as well as the comment form will be published on the deliverable specific page at the start of […]

[Closed] EUnetHTA 21 launches Open Call for JSC

EUnetHTA 21 is launching the first Open Call for applications from the pharmaceutical industry for four Joint Scientific Consultations (JSC), starting in January 2022. These will be consultations in parallel to EMA scientific advice and hence will focus on medicinal products. The Open Call will remain open from 8 November, 2021 to 7 December, 2021. […]

EUnetHTA 21 – first Stakeholder Kick-Off Meeting

EUnetHTA 21 Secretariat is pleased to announced that the first EUnetHTA 21 Stakeholder Kick-Off Meeting is scheduled, online, for 03.12.2021 at 10:30-12:00 CET.  The meeting will entail a high-level focus and will address the following points:  Introduction of the ‘new’ EUnetHTA 21 as a consortium;  Our governance principles;  Planned Stakeholder interaction (public consultations);  Presentation of the deliverables planned over the course of […]

Engaging Stakeholder in Joint Action 3 – now available for access

​​As Joint Action 3 (JA3) comes to a close, an overview of stakeholder interaction has been prepared that focusses on who our stakeholders are, the product-related progress we have made, and all related stakeholder activities through JA3.  Access here: Engaging Stakeholders in Joint Action 3​

2021 EUnetHTA Forum Welcome Guide

The 2021 EUnetHTA Forum Welcome Guide is now available. The guide forms a comprehensive overview of EUnetHTA activities as we near completion of Joint Action 3, and is recommended reading prior to the Forum on 15 April. Follow the link, or check the ‘Get Involved’ dropdown menu on our homepage and then to ‘Events’, you’ll […]